Low Dose Naltrexone

submitted by: admin on 06/24/2016

Low dose naltrexone (LDN) has been implicated to help with cancer, HIV/AIDS, autoimmune diseases, and much more. Now it has been shown to have a potent antitumor effect on human ovarian cancer in both tissue culture and in animal xenografts. Naltrexone (NTX) is a general opioid receptor antagonist that results in compensatory elevation in endogenous opioids and opioid receptors. It has a powerful inhibition of cell proliferation. Studies showed that LDN could also increase the effects of chemotherapy for ovarian cancer.

 

 

 

 

 

 

 

Take Dr. Saputo's Cancer Health Assessment

 

Once you have cancer you want to know what you can do to get rid of it and keep it gone! In this Health Assessment we will ask you questions about what treatment(s) you have undergone, which complementary and alternative treatments might be of interest to you, what lifestyle factors could help slow down or prevent a recurrence, and what you might want to consider if your cancer is causing pain or if your situation is terminal.

 

 

 

 

Take our Cancer Health Assessment

 

Part of...

Keywords for this Article